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Reverse Mode of the Na1-Ca21 Exchange After
Myocardial Stretch
Underlying Mechanism of the Slow Force Response
Néstor G. Pérez, María C. Camilión de Hurtado, Horacio E. Cingolani
Abstract—This study was designed to gain additional insight into the mechanism of the slow force response (SFR) to
stretch of cardiac muscle. SFR and changes in intracellular Na1 concentration ([Na1]i) were assessed in cat papillary
muscles stretched from 92% to ’98% of Lmax. The SFR was 12060.6% (n55) of the rapid initial phase and coincided
with an increase in [Na1]i. The SFR was markedly depressed by Na1-H1 exchanger inhibition, AT1 receptor blockade,
nonselective endothelin-receptor blockade and selective ETA-receptor blockade, extracellular Na1 removal, and
inhibition of the reverse mode of the Na1-Ca21 exchange by KB-R7943. KB-R7943 prevented the SFR but not the
increase in [Na1]i. Inhibition of endothelin-converting enzyme activity by phosphoramidon suppressed both the SFR and
the increase in [Na1]i. The SFR and the increase in [Na1]i after stretch were both present in muscles with their
endothelium (vascular and endocardial) made functionally inactive by Triton X-100. In these muscles, phosphoramidon
also suppressed the SFR and the increase in [Na1]i. The data provide evidence that the last step of the autocrine-
paracrine mechanism leading to the SFR to stretch is Ca21 entry through the reverse mode of Na1-Ca21 exchange. (Circ
Res. 2001;88:376-382.)
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In experiments performed on cat papillary muscles, wefound that stretch triggered an autocrine/paracrine mecha-
nism that activated the Na1-H1 exchange (NHE) and caused
intracellular alkalinization.1 The increase in intracellular pH
(pHi) seemed to be the result of a chain of events involving
endogenous angiotensin II (Ang II) and endothelin (ET) in
the muscles and activation of the NHE. Those experiments
were performed in the nominal absence of bicarbonate, and
the possible effect of the autocrine/paracrine mechanism on
cardiac mechanics was not analyzed. In a subsequent study2
on rat trabeculae bathed with a CO2/HCO32-buffered me-
dium, we showed the involvement of the above-mentioned
autocrine/paracrine mechanism in the generation of the slow
force response (SFR) to stretch. It is worth noting that despite
the stretch-induced activation of the NHE, changes in pHi
may not be detected in the presence of CO2/HCO32 buffer,3,4
as in the experiments on rat trabeculae,2 because of the
simultaneous activation of the Na1-independent Cl2-HCO32
exchanger (AE) by Ang II5 or ET.6
It is well-known that stretch of cardiac muscle generates a
biphasic force response, with a rapid increase in force that has
been attributed to increased myofilament Ca21 responsiveness
and a second slowly-developing phase, the SFR.2,7,8 The SFR
was described by Parmley and Chuck9 in 1973 and constitutes
the possible explanation for the Anrep effect.10–12 Previous
reports showed that neither L-type Ca21 currents13 nor the
sarcoplasmic reticulum (SR)8 contribute to the increase in
Ca21 transient during the SFR. What we do know is that
blockade of AT1 or ETA receptors prevents the increase in
Ca21 transient underlying the SFR.2
Considering these data and the fact that the blockade of the
AT1 or the ETA receptors also prevented the increase in [Na1]i
because of the enhanced activity of the NHE,2 we tested the
notion that the Na1-Ca21 exchange (NCX) mediates the
increase in contractility. NCX is a sarcolemmal transporter
that exchanges 3 Na1 for each Ca21. At resting membrane
potential, the exchanger functions in a Na1in-Ca21out mode
(forward mode); when the membrane is depolarized positive
to the exchanger reverse potential, NCX can bring Ca21 into
the cytosol and extrude Na1 (reverse mode). Studies on feline
ventricular myocytes provided evidence that NCX contrib-
utes to contraction by carrying Ca21 into the cell during the
plateau of the action potential.14 This is particularly important
under conditions in which [Na1]i increases. As pointed out by
Eisner et al,15 the dependence of twitch tension on [Na1]i is
very steep. Thus, even small changes in [Na1]i can have
substantial effects on contraction. However, evidence that the
NCX mediates SFR is still lacking. Experiments were de-
signed to answer the following questions: (1) Does the NCX
play a role in determining the SFR to stretch? (2) If the NCX
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mediates the SFR, is this effect attributable to decreased Ca21
efflux or increased Ca21 influx? (3) Do the endothelial cells in
our multicellular preparation play a role in the development
of the SFR?
Materials and Methods
The SFR to an increase in muscle length from 92% to 98% of Lmax
(termed L92 and L98, respectively) was assessed on cat papillary
muscles (0.4860.04 mm2 of cross-sectional area), isometrically
contracting at a rate of 0.2 Hz. Muscles were superfused with either
bicarbonate- or HEPES-buffered solutions; all the experiments were
performed at 30°C. Developed force (DF) in control conditions was
260.1 g/mm2 at L92 and 3.960.2 at L98. Our preparations were stable
over 45 minutes or more, as shown in Figure 3D. Possible partici-
pation of catecholamines released by the nerve endings was pre-
vented by prazosin plus atenolol (1 mmol/L). Changes in [Na1]i and
pHi were monitored by epifluorescence of sodium-binding benzol-
furan isophthatlate (SBFI) or BCECF, respectively. The effects of
the following experimental maneuvers on SFR development were
analyzed: (1) extracellular Na1 removal; (2) functional inactivation
of vascular and endocardial endothelial cells with Triton X-100
(TX)16; and (3) inhibition of NHE (1 mmol/L HOE 642), reverse
mode of NCX (5 mmol/L KB-R7943), and endothelin-converting
enzyme (ECE) (100 mmol/L phosphoramidon) activities as well as
AT1 (1 mmol/L losartan), ETA (300 nmol/L BQ 123), or nonselective
ET-receptor (0.1 or 1 mmol/L TAK 044) blockade. The drugs were
added to the perfusate 20 minutes before the stretch, and during this
period, none of them changed DF by more than 3% to 4%. To avoid
cellular Ca21 overload in nominally Na1-free solutions, Ca21 con-
centration was initially reduced to 0.1 mmol/L and then gradually
increased until reaching the same DF as in normal extracellular Na1
concentration. We allowed DF to reach steady state before stretching
the muscles.
An expanded Materials and Methods section can be found in an
online data supplement available at http://www.circresaha.org.
Results
SFR in Cat Myocardium: General Aspects
Figure 1A shows the typical biphasic force response to
stretch: a first, rapidly occurring increase and a second,
gradually developing phase (the SFR). Figure 1B shows the
force response to a second stretch on the same muscle (’30
minutes apart). Figure 1C shows that the overall increase of
DF during the SFRs elicited by 2 consecutive stretches
reached similar magnitude after 15 minutes (12060.6% first
stretch versus 11961% second stretch, n55, NS) and vali-
dates the comparison of consecutive stretches before and after
pharmacological interventions, as later presented.
Experiments were performed to verify that the autocrine/
paracrine mechanism (release of Ang II 3 release of ET 3
activation of the NHE) described in the rat as mediating the
SFR2 is also detected in cat papillary muscles. Figure 2A
shows the effect of the NHE inhibition by HOE 642.
Although perhaps predictable in light of our previous results
in rat,2 the SFR decreased after the selective blockade of the
NHE. Figure 2B shows that the blockade of AT1 receptors by
losartan diminished the SFR. To investigate the involvement
of ET, the effect of ET receptor blockade was tested. Figure
2C shows a concentration-dependent attenuation of the SFR
in the presence of TAK 044, a nonselective ET receptor
blocker. Figure 2D shows that ETA receptor blockade with
BQ 123 also caused a significant attenuation of the SFR.
These data agree with our results in rat2 showing that
ETA-receptor blockade cancelled the SFR as well as the
increase in Ca21 after the stretch. The SFR in cat myocardium
is then, as in rat,2 the result of an autocrine-paracrine
activation of the NHE by ET. The confirmation of this chain
of events leading to the SFR in cat myocardium is important,
Figure 1. Characteristic force response to the stretch in isolated
cat papillary muscle. A, Original record showing the characteris-
tic biphasic force response to stretch. B, Force response to a
second stretch on the same muscle (’30 minutes apart). C,
Averaged results for DF (in percent of the rapid phase) during
the SFRs of 2 consecutive stretches from 5 separate experi-
ments. #P,0.05 vs initial rapid phase.
Figure 2. Effect of NHE inhibition and of AT1 or ET receptor
blockade on the SFR in cat myocardium. Averaged values of
the SFR under control experimental conditions and after phar-
macological interventions. A, NHE inhibition; B, blockade of AT1
receptors; C, nonselective ET-receptor blockade; D, ETA-
receptor blockade. All of the pharmacological interventions
markedly attenuated the SFR, providing evidence that the acti-
vation of the NHE as well as the endogenous release of Ang II
and ET are prerequisites to generate the SFR in cat myocar-
dium. #P,0.05 vs initial rapid phase. For the sake of clarity, sig-
nificance is indicated only for points after 10 minutes of stretch.
*P,0.05 between control and pharmacological intervention
curves (2-way ANOVA). §P,0.05 between 0.1 and 1 mmol/L
TAK 044 (2-way ANOVA).
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because the existence of AT1 receptors or their coupling to
regulatory G proteins is controversial in adult rat cardiac
myocytes.17–19
Role Played by the NCX in the Generation
of the SFR
To explore the possible contribution of NCX activity, we
studied the effect of extracellular Na1 deprivation (either
replaced by LiCl or N-methyl-D-glucamine) on the SFR to
stretch (Figures 3A and 3B). DF was maintained under
nominally Na1-free conditions at the same level as in normal
extracellular Na1 by adjusting Ca21 concentration in the
perfusate. After Na1 withdrawal, the SFR was cancelled.
These results confirm the NCX involvement in the develop-
ment of the SFR; however, they do not enable us to define
whether this effect is mediated by the forward or the reverse
mode of exchange. It may be argued that external Na1
withdrawal inhibits the NHE, and, in this respect, these
results would provide no additional mechanistic insight than
that derived from the HOE 642 experiments. However, under
Na1-free Li1-replaced conditions, the NHE is still operative
(exchanging Li1 for H1)20 and the SFR was also abolished,
arguing in favor of the NCX as the mechanism responsible for
the SFR.
Whether the SFR is caused by the NCX operating in
forward mode (decreasing Ca21 efflux) or in reverse mode
Figure 3. Role of NCX in the generation of the SFR. Results
show that extracellular Na1 replacement by N-methyl-D-
glucamine (NMG) (A) or by lithium (Li1) (B) abolished the SFR.
KB-R7943 (C) also suppressed the SFR, supporting the idea
that the reverse mode of the NCX is responsible for this phe-
nomenon. D, KB-R7943 canceled the SFR, even if applied after
the stretch. F, Control stretch sustained for 45 minutes (n54);
Œ, KB-R7943 added 15 minutes after the onset of stretch (n54);
‚, KB-R7943 added immediately after stretch (n54). #P,0.05
vs initial rapid phase. *P,0.05 between control and pharmaco-
logical intervention curves (2-way ANOVA).
Figure 4. Absence of stretch-induced alkalinization in the pres-
ence of CO2/HCO32 (BIC)-buffered medium. A, Values of pHi
before and during the stretch in representative experiments in
nominally BIC-free (HEPES) or BIC-buffered medium. B,
Mean6SEM of maximal changes in pHi induced by stretch in
HEPES- and BIC-buffered medium. N indicates number of
experiments; *P,0.05.
Figure 5. Inhibition of the reverse mode of NCX canceled the
SFR but not the rise of [Na1]i. SFR of control muscles (E, top)
was accompanied by a significant increase in [Na1]i (bottom).
KB-R7943 (F) suppressed the SFR but not the increase in
[Na1]i. #P,0.05 vs initial rapid phase. *P,0.05 between control
and pharmacological intervention curves (2-way ANOVA). SBFI
indicates sodium-binding benzolfuran isophthatlate.
Figure 6. Effect of the specific inhibition of the ECE activity on
the SFR. Inhibition of ECE activity by phosphoramidon sup-
pressed both the SFR (top) and the rise in [Na1]i (bottom), indi-
cating that stretch increases conversion rate of big ET to ET
and that ET itself is responsible for the increase in [Na1]i and the
SFR. #P,0.05 vs initial rapid phase. *P,0.05 between control
and pharmacological intervention curves (2-way ANOVA).
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(increasing Ca21 influx) was explored next, taking advantage
of KB-R7943, a compound described as a selective inhibitor
of the reverse mode of the NCX.21,22 Figure 3C shows that the
SFR is cancelled in the presence of KB-R7943. The com-
pound also abolished the SFR applied either immediately or
15 minutes after the stretch (Figure 3D). When KB-R7943
was added at the beginning of the stretch, the development of
the SFR was interrupted after ’3 to 5 minutes, whereas the
SFR gradually decreased to the level of the initial phase with
a t1/2 of 9.162.5 minutes (n54) when it was added 15 minutes
after the stretch.
Satoh et al23 showed that 5 mmol/L of KB-R7943 selec-
tively inhibited the reverse but not the forward mode of NCX
in rat cardiomyocytes. It was recently suggested that KB-
R7943 inhibition of ET-1–induced positive inotropic effect is
attributable to the inhibition of the NCX reverse mode.24
Because other nonspecific actions of KB-R7943 were also
reported, such as prolongation of action potential duration
(APD) and inhibition of Na1, L-type Ca21, and K1 currents
that could interfere with the SFR development,22,23 the effects
of KB-R7943 on APD were analyzed in isolated cat ventric-
ular myocytes. In 4 experiments, 5 mmol/L KB-R7943 altered
neither the resting membrane potential nor the APD during
the first 10 minutes after the pharmacological intervention.
After 15 minutes, a slight but insignificant shortening of the
APD50 was detected (727651 versus 629655 ms, NS),
whereas there was no change to the APD90. The lack of effect
of KB-R7943 on APD90 compared with the ’66% increase
reported in rat myocardium,23 possibly reflecting genuine
species-dependent differences. Although APD prolongation
may be a confounding factor in the rat, it does not seem to
explain the inhibition of the SFR by KB-R7943 in cat
myocardium.
Because stretch activates NHE and an increase in pHi
would increase DF by increasing myofilament Ca21 respon-
siveness,25 the effect of stretch on pHi was explored. The pHi
response varied with the presence or absence of bicarbonate
(Figure 4). In the nominal absence of bicarbonate, pHi
increased, in agreement with our previous results.1,2 In the
presence of bicarbonate there was no significant change in
pHi after stretch, which can be explained by simultaneous
Ang II–induced or ET-1–induced activation of one acidifying
and one alkalinizing mechanism (NHE and AE).5,6
Given the fact that in bicarbonate, the expected alkaliniza-
tion after NHE activation is blunted, we sought to determine
the increase in [Na1]i as a marker of NHE activity and the
cause of the Ca21 transient increase during the SFR. Figure 5
shows that the SFR was accompanied by an increase in SBFI
fluorescence ratios that would correspond to an estimated
increase in [Na1]i of ’6 mmol/L after 10 minutes of stretch.
When muscle length was returned to L92, there was also a
return of [Na1]i toward baseline levels, with a t1/2 of 260.5
minutes. In the presence of KB-R7943, the SFR was sup-
pressed, but the increase in [Na1]i was still present (Figure 5).
These results are compatible with the idea that the NCX
Figure 7. SFR of papillary muscles with dysfunctional endothe-
lium. Both the SFR (top) and the increase in [Na1]i (bottom) are
present in papillary muscles with dysfunctional endothelium. On
these muscles, phosphoramidon abolished both the SFR and
the increase in [Na1]i. #P,0.05 vs initial rapid phase. *P,0.05
between control and pharmacological intervention curves (2-way
ANOVA).
Figure 8. Hypothetical alternative pathways to explain the SFR.
Autocrine and paracrine signaling pathways are schematized in
A and B, respectively. A, Stretch releases stored Ang II that will
bind to the AT1 receptors of the myocyte. The myocyte forms
and releases ET, which, through the ETA receptors, stimulates
NHE activity by a protein kinase C–dependent pathway. The
simultaneous activation of the acidifying mechanism (AE) pre-
cludes changes in pHi, but [Na1]i rises. The increase in [Na1]i will
activate the NCX in its reverse mode (Ca21in-Na1out), and this will
increase the [Ca21]i transient. B, Mechanism is similar to panel
A, but the source of ET is the fibroblast instead of the myocyte.
Ang II released by the myocyte stimulates AT1 receptors on
fibroblasts in a paracrine fashion, inducing the formation and
release of ET. ET released by fibroblasts will act on the ETA
receptors of myocytes in a cross-talked paracrine loop.
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operating in the reverse mode (Ca21in-Na1out mode) is the final
step that links the increase in [Na1]i, caused by the NHE
activation, to the increase in the Ca21 transient during the
SFR.2,7,8
Possible Role of Endothelial Cells on the SFR
The present results and our previous studies in the rat2
provide evidence that the release and formation of ET is a
mandatory step between Ang II and the activation of the
NHE, causing the increase in [Na1]i and the SFR. However,
it is not yet clear whether stretch-induced release of ET is
attributable to increased cleavage of big ET to ET by its
converting enzyme or to augmented release of preformed
peptide. Figure 6 shows that ECE inhibition suppressed both
the SFR and the rise in [Na1]i. This finding suggests that Ang
II increases the conversion rate of big ET and reinforces the
idea that ET itself is the last agonist of the autocrine/paracrine
mechanism. Although it was previously demonstrated that
Ang II increases prepro ET-1 mRNA levels,26 a direct Ang II
stimulatory effect on ECE activity27 should also be
considered.
To address whether endothelial cells were the source of
ET, the endocardial and vascular endothelial cells were
functionally inactivated by a 2-step pretreatment with TX,16
comprising the injection of TX in the coronaries before
dissection of the papillary muscles (vascular endothelium
inactivation) and flushing the isolated muscles with TX
(endocardial endothelium inactivation). Figure 7 shows that
after endothelial inactivation the SFR and the increase in
[Na1]i after the stretch both persisted and that both were
blocked by phosphoramidon. The increase in [Na1]i detected
after stretch was somewhat higher than in muscles having
functional endothelium. We do not have a reasonable expla-
nation for this unexpected finding. Perhaps dysfunctional
endothelial cells accumulate Na1 or interfere with its mea-
surement or the myocytes accumulate Na1 after the TX
treatment. In any case, the SFR was present even in muscles
with dysfunctional endothelium, and phosphoramidon was
able to abolish both the SFR and the increase in [Na1]i.
Therefore, these data suggest that endothelial cells are not the
source for ET. However, one should be cautious, because
although the efficacy of TX to produce endothelial dysfunc-
tion and abolish NO function are well-accepted,16 the same
rationale may not apply for the production and release of ET.
Discussion
The data presented here confirm and extend the previous
finding in the rat myocardium that the increase in the Ca21
transient generating the SFR is the result of an autocrine/
paracrine mechanism. A major novel contribution of this
study is to demonstrate the involvement of the NCX as a
mechanism responsible for the SFR. This possibility, al-
though suggested, was not proven previously.2 The experi-
ments showing the suppression of the SFR after external Na1
withdrawal strongly suggest that the NCX is required for the
development of the SFR. The abolition of the SFR by
KB-R7943 would support that NCX operating in the reverse
mode is responsible for the SFR. The rise in [Na1]i conse-
quent to the ET-induced stimulation of NHE activity shifts
the thermodynamic balance of the NCX, promoting the
reverse mode of exchange or increasing the time during
which the NCX operates in its reverse mode. Whether there is
also a contribution of a direct ET stimulatory effect on NCX28
in addition to the increase in [Na1]i is not clear. However, we
should keep in mind that the increase in [Na1]i is a mandatory
step for SFR development.
The question of why the elevation of [Na1]i is not corrected
by the Na1-K1–ATPase activity may be raised. However, we
may speculate that, similarly to the Na1 pump lag hypothesis
for the force-frequency relationship, the greater Na1 entry is
balanced by increased Na1 pump activity but only at the cost
of elevated [Na1]i and, hence, increased Ca21 entry.
In our experiments, the SFR was diminished by the ETA
blocker BQ123 and practically abolished by the nonselective
ET blocker TAK 044. These findings would be consistent
with the involvement of both the ETA and ETB subtype of
receptors in the development of the SFR. However, it has
been shown previously in rabbit myocardium that the positive
inotropic effect of ET-1 is mediated by an ETA2 subtype of
receptor that is less sensitive to BQ123 than to TAK 044.29
Besides stimulating NHE activity, ET is known to have other
potentially inotropic effects, such as those derived from its
action on L-type Ca21 or K1 currents. However, studies of the
effects of ET-1 on L-type Ca21 or K1 currents are conflict-
ing,30–33 and in our experiments the development of the SFR
was abolished by preventing the rise in [Na1]i.
Evidence regarding a possible relationship between cAMP
levels and SFR was recently presented in ferret papillary
muscles.34 An increase in cAMP was detected in the muscles
in which the SFR was present, whereas there was no increase
in cAMP when the SFR was absent. It is difficult to compare
these data with ours. In our study, it was very unusual to have
cat papillary muscles that did not develop the SFR after
stretch. Furthermore, our previous experiments1,2 and those
described here were performed in the presence of a-and
b-adrenergic receptor blockade to avoid the possible effects
of catecholamine release.
In this study, KB-R7943 prevented the SFR despite the
increase in [Na1]i. Although 5 mmol/L KB-R7943 inhibits the
reverse mode of NCX but not the forward mode in the rat
myocardium,23 we did not confirm that this is the case in cat
myocardium. The possibility that KB-R7943 at the concen-
tration used affected to some extent the forward mode of the
NCX cannot be completely denied. The increase in [Na1]i
would decrease the forward mode of NCX (Ca21out-Na1in),
increasing diastolic Ca21 and leading to greater Ca21 seques-
tration by the SR, which finally would increase Ca21 tran-
sient. Therefore, by inhibiting the forward mode of the NCX,
KB-R7943 would be capable of blocking the SFR. This
possibility is unlikely, because, first, this compound was
previously shown to inhibit mainly the reverse mode of the
NCX, acting as a competitive inhibitor with external Ca21.22
Furthermore, we2 and other investigators8 have reported the
lack of changes in diastolic Ca21 during SFR development,
and the possible role played by the SR in the SFR was
recently ruled out.8 It is interesting that, analyzing the
potential contribution of sarcolemmal ion fluxes to SFR
development in an ionic model of cardiac myocytes, Bluhm et
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al35 found that the SFR could be mimicked by an increase in
[Na1]i that concurred with an increase in Ca21 entry through
the NCX. In any case, the SFR was practically abolished by
blocking the NHE and AT1 or ETA receptors as well as by
pharmacological blockade of the NCX in reverse mode.
No changes in DF were detected when KB-R7943 was
added 20 minutes before stretching the muscle from L92 to
L98, which contrasts with the fade of the SFR when this
compound was applied after the onset of the SFR (Figure
3D). One possible explanation could be a lack of SFR to
stretches performed at lower muscle lengths, ie, from 86% to
92% of Lmax. However, stretching between these 2 lengths
promoted a SFR of similar magnitude (data not shown) to the
ones reported here. Other possibilities to be considered are
that the SFR could diminish after a certain time or would not
be sustained by an increase in the Ca21 transient because of
the reverse mode of the NCX. We do not have a clear
explanation for the lack of changes in DF after the addition of
KB-R7943 in control conditions.
The fact that the inhibition of the ECE by phosphoramidon
prevented the rise in [Na1]i and the SFR allows us to conclude
that the stretch (through AT1 receptors) enhances the conver-
sion of big ET to ET instead of promoting the release of
previously formed and stored ET. ECE was originally de-
scribed to be expressed on cell membrane with the catalytic
site in the extracellular domain.36 Two ECE isoforms (ECE-1
and ECE-2) can be differentiated by their optimum pH and
sensitivity to phosphoramidon (ECE-2 ’250-fold more sen-
sitive than ECE-1).37 We chose for our study a phosphoram-
idon concentration that assured complete inhibition of both
isoforms38; thus, we cannot distinguish which isoform is
involved. Yamazaki et al39 showed that ET-1 was constitu-
tively released by neonatal rat cardiomyocytes and that ET-1
mRNA levels were increased by stretch. In the same study,
the authors proposed that ET and Ang II synergistically
mediate the hypertrophic response to stretch. Our present
results showing the suppression of the SFR with phosphor-
amidon as well as with TAK 044 strongly favor the idea that
ET alone is the final mediator of the autocrine/paracrine
mechanism leading to the SFR, at least in adult myocardium.
The presence of SFR in muscles with vascular and endo-
cardial endothelial cells functionally inactive indicates, de-
spite the limitations of the method, that Ang II and ET are
released by cells other than endothelial ones. Ang II and ET
can be produced either by myocytes or fibroblasts. We do not
have any evidence of which cell type is the source of the
peptides. In this regard, two topics merit consideration. First,
the SFR can be detected in isolated rat myocytes.13 Although
this finding supports the theory of an autocrine mechanism,
we should keep in mind that fibroblasts may contaminate
isolated myocyte preparations.40 Second, the SFR was de-
tected in our previous study on adult rat trabeculae2 despite
the fact that the presence of AT1 receptors and their coupling
to regulatory G proteins have been disputed in adult rat
cardiac myocytes.17–20 Because acute stretch can stimulate the
release of prestored Ang II from myocytes but not from
fibroblasts,41 the alternative of a paracrine pathway may be
proposed. Whereas in an autocrine mechanism the myocyte
will be the source and the target of Ang II and ET (as
schematized in Figure 8), in the paracrine mechanism the Ang
II released by the myocytes will bind the AT1 receptors of rat
fibroblasts, where they are highly expressed.42 The activation
of AT1 receptors on fibroblasts will induce the formation or
release of ET by these cells. ET, also in a paracrine fashion,
will act on the myocytes, rich in ETA receptors,18 and will
increase [Na1]i through the stimulation of the NHE and
[Ca21]i through the NCX operating in reverse mode. This
hypothesis is consistent with a previous report that ET-1
produced by nonmyocyte cells regulates myocyte growth in a
paracrine fashion.43
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